Trial Profile
Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen (CENTER).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms CENTER
- 31 Mar 2010 Actual end date (April 2008) added as reported by ClinicalTrials.gov.
- 31 Mar 2010 Actual number of patients added to 14478 as reported by ClinicalTrials.gov.
- 30 Jan 2009 Actual initiation date (Jun 2007) added as reported by ClinicalTrials.gov.